Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nuvanta sdn. bhd. - dibasic calcium phosphate dihydrate; zinc citrate; magnesium amino acid chelate; magnesium oxide; ascorbic acid; calcium citrate; pottasium citrate; calcium carbonate; calcium amino acid chelate -

Kenya - English - Pharmacy and Poisons Board

mega lifesciences ltd 384 soi 6 pattana 3 road bangpoo industrial - dibasic calcium phosphate calcium carbonate… - capsule - dibasic calcium phosphate 150mg calcium carbonate… - mineral supplements: calcium combinations with

Kenya - English - Pharmacy and Poisons Board

nabiqasim industries (pvt). ltd. 5th floor commerce centre hasrat mohani road - monobasic sodium phosphate + dibasic sodium… - enema - monobasic sodium phosphate 19.2g + dibasic sodium… - drugs for constipation: osmotically acting

Malta - English - Medicines Authority

lab. chimico farmaceutico a sella s.r.l via vicenza 67, schio, italy - sodium phosphate, dibasic dodecahydrate, monobasic dihydrate - rectal solution - sodium phosphate dibasic dodecahydrate 8 % (w/v) sodium phosphate monobasic dihydrate 18.1 % (w/v) - drugs for constipation

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - calcium chloride dihydrate, quantity: 3.68 g/l; magnesium chloride hexahydrate, quantity: 2.44 g/l - solution, dialysis - excipient ingredients: hydrochloric acid; water for injections - phoxilium 1.2 mmol/l phosphate solution is used as a substitution solution and/or as a dialysis solution for crrt (continuous renal replacement therapy) in critically ill patients with acute kidney injury (aki) when ph and kalaemia have been restored to normal and when the patients need phosphate supplementation for loss of phosphate in the ultrafiltrate or to the dialysate during crrt.,phoxilium 1.2 mmol/l phosphate solution may also be used in case of drug poisoning or intoxications when the poisons are dialysable or pass through the membrane.,in these patient groups, phoxilium 1.2 mmol/l phosphate solution is indicated for use in patients with normal kalaemia and normal or hypophosphataemia.

Canada - English - Health Canada

chester labs, inc. - sodium phosphate monobasic; sodium phosphate dibasic - enema - 16g; 6g - sodium phosphate monobasic 16g; sodium phosphate dibasic 6g - cathartics and laxatives

Canada - English - Health Canada

sandoz canada incorporated - sodium phosphate monobasic; sodium phosphate dibasic - solution - 276mg; 268mg - sodium phosphate monobasic 276mg; sodium phosphate dibasic 268mg - replacement preparations

Canada - English - Health Canada

pharmascience inc - sodium phosphate monobasic; sodium phosphate dibasic - solution - 480mg; 180mg - sodium phosphate monobasic 480mg; sodium phosphate dibasic 180mg - cathartics and laxatives

Canada - English - Health Canada

euro-pharm international canada inc - sodium phosphate monobasic; sodium phosphate dibasic, heptahydrate - solution - 0.48g; 0.18g - sodium phosphate monobasic 0.48g; sodium phosphate dibasic, heptahydrate 0.18g - cathartics and laxatives

United States - English - NLM (National Library of Medicine)

avkare, inc. - sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295o53k152), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium phosphate, dibasic, anhydrous 852 mg - as a phosphorus supplement, each tablet supplies 25% of the u.s. recommended daily allowance (u.s. rda) of phosphorus for adults and children over 4 years of age. av-phos 250 neutral increases urinary phosphate and pyrophosphate. this product is contraindicated in patients with infected phosphate stones in the urinary tract, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.